Market Research Logo

Benign Prostatic Hyperplasia Pipeline Highlights – 2017 Update

Benign Prostatic Hyperplasia Pipeline Highlights – 2017 Update

The latest report from Fore Pharma, Benign Prostatic Hyperplasia Pipeline Highlights – 2017 Update, provides most up-to-date information on key pipeline products in the global Benign Prostatic Hyperplasia market. It covers emerging therapies for Benign Prostatic Hyperplasia in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:
The report provides Benign Prostatic Hyperplasia pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:
The report provides Benign Prostatic Hyperplasia pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:
The report provides Benign Prostatic Hyperplasia pipeline products by the company.

Short-term Launch Highlights:
Find out which Benign Prostatic Hyperplasia pipeline products will be launched in the US and Ex-US till 2020.

SUMMARY:

  • Benign Prostatic Hyperplasia phase 3 clinical trial pipeline products
  • Benign Prostatic Hyperplasia phase 2 clinical trial pipeline products
  • Benign Prostatic Hyperplasia phase 1 clinical trial pipeline products
  • Benign Prostatic Hyperplasia preclinical research pipeline products
  • Benign Prostatic Hyperplasia discovery stage pipeline products
  • Benign Prostatic Hyperplasia pipeline products short-term launch highlights


1. Benign Prostatic Hyperplasia Pipeline by Stages
2. Benign Prostatic Hyperplasia Pipeline by Drug Class
3. Benign Prostatic Hyperplasia Pipeline by Company
4. Benign Prostatic Hyperplasia Phase 3 Clinical Trial Insights
5. Benign Prostatic Hyperplasia Phase 2 Clinical Trial Insights
6. Benign Prostatic Hyperplasia Phase 1 Clinical Trial Insights
7. Benign Prostatic Hyperplasia Preclinical Research Insights
8. Benign Prostatic Hyperplasia Discovery Stage Insights
9. Appendix
10. Research Methodology
LIST OF TABLES
Table 1: Benign Prostatic Hyperplasia Phase 3 Clinical Trials, 2017
Table 2: Benign Prostatic Hyperplasia Phase 2 Clinical Trials, 2017
Table 3: Benign Prostatic Hyperplasia Phase 1 Clinical Trials, 2017
Table 4: Benign Prostatic Hyperplasia Preclinical Research, 2017
Table 5: Benign Prostatic Hyperplasia Discovery Stage, 2017
LIST OF FIGURES
Figure 1: Benign Prostatic Hyperplasia Pipeline Molecules by Clinical Trials Stage, 2017
Figure 2: Benign Prostatic Hyperplasia Pipeline Molecules by Drug Class, 2017
Figure 3: Benign Prostatic Hyperplasia Pipeline Molecules by Company, 2017
Figure 4: Benign Prostatic Hyperplasia Phase 3 Clinical Trial Highlights, 2017
Figure 5: Benign Prostatic Hyperplasia Phase 2 Clinical Trial Highlights, 2017
Figure 6: Benign Prostatic Hyperplasia Phase 1 Clinical Trial Highlights, 2017
Figure 7: Benign Prostatic Hyperplasia Preclinical Research Highlights, 2017
Figure 8: Benign Prostatic Hyperplasia Discovery Stage Highlights, 2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report